The A/A genotype of an interleukin-17A polymorphism predisposes to increased severity of atopic dermatitis and coexistence with asthma

Clinical and Experimental Dermatology

Volumn 40, Issue 1, 2016, Pages 11-16

  Narbutt, J ^a   Wojtczak, M ^a   Zalinska A ^a   Salinski, A ^a   Przybylowska Sygut, K ^a   Kuna, P ^a   Majak, P ^a   Sysa Jedrzejowska, A ^a   Lesiak, A ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23 RECEPTOR; IL23R PROTEIN, HUMAN; INTERLEUKIN RECEPTOR;

ADOLESCENT; ADULT; ALLELE; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHILD; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POLISH CITIZEN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TH17 CELL; CASE CONTROL STUDY; COMPLICATION; DERMATITIS, ATOPIC; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; INFANT; POLAND; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; ALLELES; ASTHMA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; INFANT; INTERLEUKIN-17; MALE; POLAND; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84917742054     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12438     Document Type: Article

References (25)

1. Silverberg JI, Hanifin JM,. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol 2013; 132: 1132-8.
2. Paternoster L, Standl M, Chih-Mei C, et al,. Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis. Nat Genet 2011; 44: 187-92.
3. Pastar ZH, Lipozencic J, Ljubojevic S,. Etiopathogenesis of atopic dermatitis-an overview. Acta Dermatovenerol Croat 2005; 1: 54-62.
4. Di Cesare A, Di Meglio P, Nestle FO,. A role for Th17 cells in the immunopathogenesis of atopic dermatitis? J Invest Dermatol 2008; 128: 2569-71.
5. Hisakata Y,. Current perspectives on the role of IL-17 in autoimmune disease. J Inflamm Res 2010; 3: 33-44.
6. Bettelli E, Oukka M, Kuchroo VK,. T(h)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8: 345-50.
7. Lupardus PL, Garcia KC,. The structure of interleukin-23 reveals the molecular basis of p40 subunit sharing with IL-12. J Mol Biol 2008; 382: 931-41.
8. Hanifin JM, Rajka G,. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980; 92: 44-7.
9. Rajka G, Langeland T,. Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989; 144: 13-14.
10. Peric M, Koglin S, Dombrowski Y, et al,. Vitamin D analogs differentially control antimicrobial peptide "alarmin" expression in psoriasis. PLoS ONE 2009; 4: e6340.
11. Souwer Y, Szegedi K, Kapsenberg ML, et al,. IL-17 and IL-22 in atopic allergic disease. Curr Opin Immunol 2010; 22: 821.
12. Kiyohara C, Tanaka K, Miyake Y,. Genetic susceptibility to atopic dermatitis. Allergol Int 2008; 57: 39-56.
13. Zitnik SE, Rüschendorf F, Müller S, et al,. IL13 variants are associated with total serum IgE and early sensitization to food allergens in children with atopic dermatitis. Pediatr Allergy Immunol 2009; 20: 551-5.
14. Lesiak A, Kuna P, Zakrzewski M, et al,. Combined occurrence of filaggrin mutations and IL-10 or IL-13 polymorphisms predisposes to atopic dermatitis. Exp Dermatol 2011; 20: 491-5.
15. Zhu S, Qian Y,. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential. Clin Sci (Lond) 2012; 122: 487-511.
16. Eyerich S, Onken AT, Weidinger S, et al,. Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med 2011; 365: 231-8.
17. Wakashin H, Hirose K, Maezawa Y, et al,. IL-23 and Thl7 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 2008; 178: 1023-32.
18. Chen J, Deng Y, Zhao J, et al,. The polymorphism of IL-17 G-152A was associated with childhood asthma. J Clin Immunol 2010; 30: 539-45.
19. Ma L, Xue HB, Guan XH, et al,. Possible role of Th17 cells and IL-17 in the pathogenesis of atopic dermatitis in northern China. J Dermatol Sci 2012; 68: 66-8.
20. Koga C, Kabashima K, Shiraishi N, et al,. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008; 128: 2625-30.
21. Shibata S, Saeki H, Tsunemib Y, et al,. IL-17F single nucleotide polymorphism is not associated with psoriasis vulgaris or atopic dermatitis in the Japanese population. J Dermatol Sci 2009; 53: 163-5.
22. Di Cesare A, Di Meglio P, Nestle FO,. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 2009; 129: 1339-50.
23. Paradowska-Gorycka A, Grzybowska-Kowalczyk E, Wojtecka-Lukasik S, Maslinski G,. IL-23 in the pathogenesis of rheumatoid arthritis. Scand J Immunol 2010; 71: 134-45.
24. Langrish CL, Chen Y, Blumenschein WM, et al,. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233-40.
25. Di Meglio P, Di Cesare A, Laggner U, et al,. The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans. PLoS ONE 2011; 6: e17160.